Thrombolytic therapy for stroke patients on blood thinners
Official title: Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on Direct Oral Anticoagulants - A Prospective Multicenter Study
Run by Chinese University of Hong Kong · NCT06241677 · Data updated 2026-11-12
This study is testing if a specific stroke treatment can be safely used in patients who were on blood thinners before their stroke to see if it helps them recover better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 260 (estimated) |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | April 15, 2024 |
| Main results expected | December 12, 2028 |
| Study ends | March 31, 2029 |
| Registry record updated | February 24, 2026 |
| Trial ID | NCT06241677 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who have experienced an acute ischemic stroke while on DOACs within the specified time frame.
✕Probably not a fit
Patients with contraindications to thrombolytic therapy or those with significant bleeding risks unrelated to DOAC use may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the safety and efficacy of intravenous thrombolytic therapy (IVT) in patients experiencing acute ischemic stroke while on direct oral anticoagulants (DOACs). It aims to recruit patients who have taken DOACs within 12-48 hours prior to their stroke and assess their neurological outcomes after receiving IVT. The study will compare these patients to a matched cohort who did not receive IVT to determine if IVT can be safely administered without increasing the risk of intracerebral bleeding. The research is being conducted at the Chinese University of Hong Kong and several collaborating hospitals.
Why it matters
Potential benefit: If successful, this study could provide a new treatment option for stroke patients on DOACs, potentially improving their recovery outcomes.
How similar studies have gone: While there is limited evidence on this specific approach, the study addresses a significant clinical dilemma that has not been extensively tested in prior research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Acute ischemic stroke patients with a last-known-well to presentation time within 4.5 hours 2. Patients who took any doses of apixaban (2.5mg or 5mg twice daily), dabigatran (110mg or 150mg twice daily), edoxaban (30mg or 60mg daily) or rivaroxaban (15mg or 20mg daily) 12-48 hours before presentation 3. National Institute of Health Stroke Scale (NIHSS) ≥ 3 4. Alberta Stroke Programme Early CT (ASPECT) score ≥ 6 5. Pre-morbid modified Rankin Scale (mRS) ≤ 3 6. Patients aged ≥ 18 years old Exclusion Criteria: 1. Initial CT brain showing intracranial haemorrhage 2. Contraindications to IVT according to current guideline recommendations \[5\], except for the use of DOAC within 12-48 hours 3. Patients with an estimated glomerular filtration rate of ≤ 30ml/min/1.73m2 4. Patients with bleeding propensities apart from the use of DOAC, e.g. platelet count of \< 100x109/L 5. Patients with significant head injury immediately prior to presentation
Where it's running
-
Chinese University of Hong Kong
Hong Kong, Hong Kong Recruiting
Study contacts
- Principal investigator: Bonaventure Yiu Ming Ip, MB ChB — Chinese University of Hong Kong
- Study coordinator: Yiu Ming Bonaventure Ip, MB ChB
- Email: bonaventureip@cuhk.edu.hk
- Phone: +852-26352152
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Music therapy after stroke
This trial tests whether adding music therapy to standard care helps stroke patients sleep better and feel less anxious or depressed while in the hospital.
-
Improving arm use after stroke with therapy and sensory techniques
This study is testing if adding sensory techniques to a therapy for stroke patients can help them use their affected arm better after treatment.
-
Therapy to improve arm use in adults after mild stroke
This study is testing a special therapy to help adults who had a mild stroke use their affected arm better in daily activities.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.